Barbara Ghent, N/A (she/her/hers)

Senior Scientist, Clinical Pharmacology
Arvinas Operations, Inc.

Poster(s):

• PII-109 - DRUG-DRUG INTERACTION (DDI) STUDY OF THE PROTEOLYSIS TARGETING CHIMERA (PROTAC) ANDROGEN RECEPTOR (AR) DEGRADER BAVDEGALUTAMIDE IN COMBINATION WITH THE P-GLYCOPROTEIN (P-GP) SUBSTRATE FEXOFENADINE IN HEALTHY MALE VOLUNTEERS.
  Thursday, March 28, 2024

  5:00 PM – 6:30 PM MDT